Physician profile
Bennett Myers
NPI 1437211414
$431,698.39
in general payments reported to CMS, 2019-2025
92 companies · $68K in 2025
The $68K reported for 2025 was more than what 97% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $36K · 2021: $30K · 2022: $75K · 2023: $63K · 2024: $88K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $141K · Consulting Fee: $35K · Travel and Lodging: $19K · Food and Beverage: $17K · Honoraria: $7,150 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $141,432.00 |
| Consulting Fee | $34,516.25 |
| Travel and Lodging | $18,769.62 |
| Food and Beverage | $16,731.07 |
| Honoraria | $7,150.00 |
| Education | $164.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $110,113.29 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Argenx US, INC. | $83,089.36 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Biogen, INC. | $74,648.64 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Abbvie INC. | $39,696.14 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $28,176.35 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $14,023.20 | 2019-2025 | |
| Amgen INC. | $13,292.57 | 2019-2025 | Uplizna, Tavneos, Tepezza |
| Emd Serono, INC. | $9,334.71 | 2019-2025 | Mavenclad |
| Horizon Therapeutics Plc | $9,197.60 | 2021-2023 | Uplizna, Tepezza |
| Ucb, INC. | $7,728.59 | 2019-2025 | Zilbrysq, Rystiggo, Briviact |
| Celgene Corporation | $7,268.78 | 2019-2025 | Zeposia |
| Janssen Scientific Affairs, LLC | $4,620.00 | 2023-2024 | |
| Merz North America, INC. | $3,918.63 | 2019-2020 | |
| Hoffmann-La Roche Limited | $2,893.59 | 2019-2022 | |
| F. Hoffmann-La Roche Ag | $2,400.00 | 2020 |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $2,132.38 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Merz Pharmaceuticals, LLC | $2,131.22 | 2021-2025 | Xeomin, Inbrija |
| Invivyd INC | $1,455.27 | 2025 | Pemgarda |
| Mdd US Operations, LLC | $1,351.86 | 2019-2025 | Gocovri, Apokyn, Gocovri |
| Teva Pharmaceuticals USA, INC. | $988.89 | 2019-2025 | Austedo, Austedo Xr, Austedo Xr |
| Tg Therapeutics, INC. | $961.35 | 2023-2025 | |
| Banner Life Sciences, LLC | $873.86 | 2020-2022 | |
| Neurocrine Biosciences, INC. | $814.00 | 2019-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $725.67 | 2019-2025 | |
| Tanabe Pharma America, INC. | $566.69 | 2019-2025 | Radicava |
| Avanir Pharmaceuticals, INC. | $554.96 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $489.77 | 2019-2025 | Onpattro |
| Kyowa Kirin, INC. | $472.61 | 2019-2024 | Nourianz |
| Ge Healthcare | $410.13 | 2019-2025 | |
| Lundbeck LLC | $356.71 | 2019-2025 | Vyepti |
| Genzyme Corporation | $351.78 | 2019-2025 | |
| Adamas Pharmaceuticals, INC. | $335.91 | 2019-2021 | |
| Roche Products Limited | $327.42 | 2023 | |
| Acadia Pharmaceuticals INC | $318.65 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $316.74 | 2020-2025 | Acthar |
| Allergan, INC. | $312.91 | 2019-2022 | |
| Edw Pharma, INC. | $273.20 | 2019 | |
| Nevro Corp. | $264.62 | 2021-2024 | Senza |
| Otsuka America Pharmaceutical, INC. | $263.80 | 2023-2024 | Nuedexta |
| Catalyst Pharmaceuticals, INC. | $251.09 | 2022-2025 | Firdapse |
| Eisai INC. | $244.49 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $235.83 | 2020-2022 | |
| Csl Behring | $211.71 | 2019-2025 | Hizentra |
| Lilly USA, LLC | $195.62 | 2020-2025 | Reyvow, Emgality, Kisunla |
| Revance Therapeutics, INC. | $186.57 | 2024-2025 | Daxxify |
| Biohaven Pharmaceutical Holding Company Ltd. | $170.16 | 2022 | |
| Jazz Pharmaceuticals INC. | $161.83 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $145.01 | 2021-2025 | Crexont, Rytary, Ongentys |
| E.R. Squibb & Sons, L.L.C. | $134.42 | 2020-2021 | |
| Grifols USA, LLC | $132.31 | 2022-2025 | Gamunex-C |
| Abbott Laboratories | $128.19 | 2019-2022 | |
| Sk Life Science, INC. | $123.40 | 2021-2023 | |
| Ipsen Biopharmaceuticals, INC | $120.75 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $119.01 | 2021-2025 | Qelbree |
| Mallinckrodt Enterprises LLC | $111.60 | 2019 | |
| Grt US Holding, INC. | $107.10 | 2021-2022 | |
| Greenwich Biosciences, INC. | $106.92 | 2019-2021 | |
| Akcea Therapeutics, INC. | $105.80 | 2019-2021 | |
| Averitas Pharma INC. | $90.54 | 2024-2025 | Qutenza |
| Sanofi-Aventis U.S. LLC | $90.18 | 2019-2020 | |
| Octapharma USA, INC. | $84.68 | 2022-2025 | Panzyga |
| Harmony Biosciences LLC | $82.54 | 2020-2025 | Wakix |
| Upsher-Smith Laboratories LLC | $76.27 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.12 | 2023-2025 | Hyqvia, Gammagard |
| Acorda Therapeutics, INC | $61.78 | 2020-2023 | Ampyra, Inbrija |
| Arbor Pharmaceuticals, INC. | $60.58 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $58.31 | 2025 | Ponvory |
| Biohaven Pharmaceuticals, INC. | $54.68 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $54.55 | 2024-2025 | Wainua |
| Janssen Biotech, INC. | $50.66 | 2025 | |
| Scilex Pharmaceuticals INC. | $48.03 | 2021-2023 | Ztlido |
| Ani Pharmaceuticals, INC. | $47.45 | 2025 | Purified Cortrophin Gel |
| Livanova USA, INC. | $44.70 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Cycle Pharmaceuticals INC | $32.17 | 2024 | Ormalvi |
| Axsome Therapeutics, INC. | $28.15 | 2023-2024 | Sunosi |
| Roche Diagnostics Corporation | $22.50 | 2024 | Cobas Pro Ise Analytical Unit |
| Sarepta Therapeutics, INC. | $21.38 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.53 | 2022 | |
| Sobi, INC | $17.89 | 2021 | |
| Fresenius Kabi USA, LLC | $17.52 | 2025 | |
| Azurity Pharmaceuticals, INC. | $17.05 | 2023 | Horizant |
| Globus Medical, INC. | $15.28 | 2025 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $13.28 | 2019 | |
| Idorsia Pharmaceuticals US INC | $12.84 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $12.75 | 2023 | Relyvrio |
| Avion Pharmaceuticals | $12.42 | 2022 | |
| Ptc Therapeutics, INC. | $12.33 | 2019 | |
| Assertio Therapeutics, INC. | $11.70 | 2020 | |
| Endo Pharmaceuticals INC. | $10.87 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,091,076.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.